loanDepot (NYSE:LDI) Price Target Raised to $2.70 at The Goldman Sachs Group

loanDepot (NYSE:LDI - Free Report) had its price objective increased by The Goldman Sachs Group from $1.70 to $2.70 in a research note released on Thursday morning,Benzinga reports. They currently have a sell rating on the stock.

Separately, UBS Group lifted their price objective on shares of loanDepot from $2.30 to $2.50 and gave the stock a "neutral" rating in a research report on Thursday, September 5th.

loanDepot Stock Performance

Shares of NYSE LDI traded down $0.03 during trading on Thursday, reaching $2.56. The stock had a trading volume of 1,264,581 shares, compared to its average volume of 598,488. The stock has a market cap of $830.77 million, a PE ratio of -4.91 and a beta of 3.46. loanDepot has a one year low of $1.52 and a one year high of $3.71. The firm's 50 day moving average price is $2.43 and its two-hundred day moving average price is $2.22. The company has a debt-to-equity ratio of 4.69, a quick ratio of 1.18 and a current ratio of 1.18.

Insider Buying and Selling

In other loanDepot news, insider Jeff Alexander Walsh sold 66,666 shares of the company's stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $2.53, for a total transaction of $168,664.98. Following the sale, the insider now directly owns 3,938,792 shares of the company's stock, valued at approximately $9,965,143.76. This represents a 1.66 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Anthony Li Hsieh sold 268,689 shares of the business's stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $2.88, for a total value of $773,824.32. Following the completion of the transaction, the director now directly owns 3,510,957 shares in the company, valued at $10,111,556.16. The trade was a 7.11 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 2,818,125 shares of company stock valued at $7,284,420 over the last quarter. Corporate insiders own 83.04% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the stock. Empowered Funds LLC boosted its stake in shares of loanDepot by 8.2% in the 1st quarter. Empowered Funds LLC now owns 205,910 shares of the company's stock valued at $533,000 after purchasing an additional 15,565 shares during the last quarter. DC Investments Management LLC bought a new stake in shares of loanDepot during the 1st quarter valued at $559,000. Cetera Advisors LLC raised its position in shares of loanDepot by 66.3% during the 1st quarter. Cetera Advisors LLC now owns 113,354 shares of the company's stock valued at $294,000 after acquiring an additional 45,173 shares during the last quarter. Wolverine Asset Management LLC lifted its stake in shares of loanDepot by 6.0% in the 2nd quarter. Wolverine Asset Management LLC now owns 1,019,910 shares of the company's stock valued at $1,683,000 after purchasing an additional 57,546 shares during the period. Finally, American Century Companies Inc. boosted its position in shares of loanDepot by 27.3% in the 2nd quarter. American Century Companies Inc. now owns 91,701 shares of the company's stock worth $151,000 after purchasing an additional 19,655 shares during the last quarter. Institutional investors own 39.39% of the company's stock.

About loanDepot

loanDepot, Inc engages in originating, financing, selling, and servicing residential mortgage loans in the United States. The company offers conventional agency-conforming and prime jumbo, federal assistance residential mortgage, and home equity loans. It also provides settlement services, which include captive title and escrow business; real estate services that cover captive real estate referral business; and insurance services, including services to homeowners, as well as other consumer insurance policies.